Four executives from Shanghai Pharmaceutical Group and subordinate companies listed in Shanghai and Hong Kong are investigated for serious disciplinary violations, showing that the Chinese medical anti -corruption storm that has set off in July is continuing to upgrade.Interviewees pointed out that the institutional defects of the Chinese medical system are the hotbed of long -term corruption, and there are systematic corruption in the medical field, not simple personal behavior.
According to the news released by the Supervision Committee of the Minhang District Discipline Inspection Commission of Shanghai, the four executives investigated were the former vice president of Shanghai Pharmaceutical Group and the former chairman of Shanghai Shangko Medical Co., Ltd. Pan Deqing, and ShanghaiLi Ping, general manager of Shangke Pharmaceutical Co., Ltd., Chen Binhua, former general manager of Shanghai Shangye Pharmaceutical Pharmaceutical Co., Ltd., and Huang Zhenhui, former deputy general manager.
The report said that Pan Deqing, Li Ping and Chen Binhua were suspected of serious disciplinary violations, while Huang Zhenhui was suspected of serious violations.
The day before the news of the four people was investigated, Shanghai Medicine had issued an announcement saying that Pan Deqing resigned from the company's vice president and all the positions held in the company's subsidiaries.Essence
Shanghai Pharmaceuticals ranked Fortune 500 and the top 50 global pharmaceutical companies, and the comprehensive strength ranks among the top three in Chinese pharmaceutical companies.The company's four executives were investigated at the same time, indicating that the recently set off for medical anti -corruption operations are further promoting.
One week later, the State Supervision Commission of the CPC Central Committee of the Communist Party of China held a mobilization meeting to deploy discipline inspection and supervision organs to cooperate with this centralized rectification.The meeting requested to carry out in -depth system governance of the entire area of the pharmaceutical industry, full -chain, and full coverage, increase discipline and law enforcement, pay close attention to leading cadres and key positions, insist on bribery and bribery together, concentrate to investigate and deal with a group of corruption cases in the pharmaceutical field.Formation of deterrence.
In many places, Central rectification reporting method .Some of the documents on the Internet also show that some places require medical staff to take the initiative to clear their lectures, training fees, and discussion fees since 2018, showing that the anti -corruption storm must be investigated for at least five years.
Since July, there have been public officials at all levels of medical systems at all levels, senior management of hospitals, and senior management of pharmaceutical companies.Some analysts believe that the significant strength of anti -corruption is not only to rectify the medical team, but also to reduce per capita medical expenditure, especially the important medical expenditure source of the hospital's prescription.
Chen Ying, the executive director of Beijing Baoci Asset Management Co., Ltd., wrote in Caixin that the existence of grass -roots doctors' wages in the medical field for many years is generally not high.Revenue supplement, its long -term and common existence and even become industry rules.
She believes that medical anti -corruption has always been carried out, and in July this year, it is determined to be so big. Many key hospitals have been investigated, which indicates that the strength of medical reform is unprecedented. The reform has reached the deep water area. When it is touched by deep interestsEssence
Scholars of interviewees pointed out that the root cause of Chinese medical corruption is still in the system.Lu Xi, an assistant professor at the School of Public Policy of the National University of Singapore, said in an interview with Lianhe Morning Post: "The system gap in the entire medical system has led to the breeding of corruption."
He explained that, first of all, the supply of Chinese medical resources compared with the needs of the entire society, there is a serious deficiency."When there is a shortage of public services such as medical care, the supplier will have a large number of rent -seeking and corruption behavior."
Secondly, there are a large number of systematic corruption in Chinese doctors' income, and their book income has not reached the social income that doctors should have.
Lu Xi said that based on these two reasons, corruption in the field of Chinese medical care is usually more than only a doctor and dean's personal behavior, which often involves all departments under a hospital.
He believes that through anti -corruption caught people, it can target some drug prices, but if systematic reforms cannot be carried out, such as promoting the hierarchical diagnosis and treatment system, increasing medical talent training, improving doctors' treatment, increasing medical investment, introducing social capital supplementary public publicServices, etc., will eventually reduce the enthusiasm of doctors' treatment.
